BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15591764)

  • 1. Cardiovascular disease and risk factors: the role of growth hormone.
    Isgaard J
    Horm Res; 2004; 62 Suppl 4():31-8. PubMed ID: 15591764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term challenges in growth hormone treatment.
    Leal Cerro A
    Horm Res; 2004; 62 Suppl 4():23-30. PubMed ID: 15591763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of growth hormone treatment: potential risks and benefits.
    Colao A
    Horm Res; 2004; 62 Suppl 3():42-50. PubMed ID: 15539798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.
    Colao A; Di Somma C; Savanelli MC; De Leo M; Lombardi G
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S41-8. PubMed ID: 16690338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
    Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepping into adulthood: the transition period.
    Shalet S
    Horm Res; 2004; 62 Suppl 4():15-22. PubMed ID: 15591762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
    Szczepańiska Kostro J; Tołwińska J; Urban M; Gardziejczyk M; Głowińska B
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and glucose homeostasis.
    Jørgensen JO; Krag M; Jessen N; Nørrelund H; Vestergaard ET; Møller N; Christiansen JS
    Horm Res; 2004; 62 Suppl 3():51-5. PubMed ID: 15539799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone replacement therapy on pituitary hormone secretion and hormone replacement therapies in GHD adults.
    Hubina E; Mersebach H; Rasmussen AK; Juul A; Sneppen SB; Góth MI; Feldt-Rasmussen U
    Horm Res; 2004; 61(5):211-7. PubMed ID: 14752209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on early cardiovascular and metabolic risk factors in children and adolescents affected with growth hormone deficiency.
    Capalbo D; Esposito A; Di Mase R; Barbieri F; Parenti G; Vajro P; Pignata C; Salerno M
    Minerva Endocrinol; 2012 Dec; 37(4):379-89. PubMed ID: 23235193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and the cardiovascular system.
    Palmeiro CR; Anand R; Dardi IK; Balasubramaniyam N; Schwarcz MD; Weiss IA
    Cardiol Rev; 2012; 20(4):197-207. PubMed ID: 22314142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
    Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
    Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
    J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.